PODTECH has completed a scalable, relocatable, prefabricated modular biopharma manufacturing facility for Bioventure Healthcare, a subsidiary of Mubadala Bio.
The facility is designed to manufacture hormone medicines and expands Bioventure's local production capacity in the UAE.
The facility comprises 14 PODULE units covering 250 sqm, designed for oral solid dosage (OSD) hormone medicines.
It includes ISO 8-classified cleanrooms, a secondary packaging area, quality control laboratories and a microbiology lab with sterility testing.
A micro-isolator provides OSD containment and a sterility isolator supports the microbiology work.
PodTech designed and installed the complete HVAC system, along with a continuous pressure monitoring, control and alarm system.
Pass boxes and air showers control the movement of materials and people into the clean areas.
PodTech manufactured the units at its UAE factory and ran factory acceptance testing (FAT) before shipment.
On site, the units were connected plug-and-play and passed site acceptance testing. PodTech's scope covered design, engineering, MEP, HVAC and validation.
The project comes as Mubadala Bio expands local production of hormone and high-potency medicines, part of its wider push to strengthen national drug security and reduce reliance on imports.
Building that capacity with prefabricated units moves most construction and testing off-site and away from live operations.
PodTech says the approach can cut project schedules by up to 50% compared with traditional factory construction.
